{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T01:33:23Z","timestamp":1696988003167},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1007\/s00105-006-1253-1","type":"journal-article","created":{"date-parts":[[2006,11,24]],"date-time":"2006-11-24T16:18:28Z","timestamp":1164385108000},"page":"1143-1153","source":"Crossref","is-referenced-by-count":1,"title":["Therapie von Hautmetastasen beim malignen Melanom"],"prefix":"10.1007","volume":"57","author":[{"given":"P.","family":"Rehberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Eppinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1253_CR1","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"Balch","year":"2001","unstructured":"Balch CM, Soong SJ, Gershenwald JE et al. (2001) Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19: 3622\u20133634","journal-title":"J Clin Oncol"},{"key":"1253_CR2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000063904","volume":"205","author":"Bong","year":"2002","unstructured":"Bong AB, Bonnekoh B, Franke I et al. (2002) Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma. Dermatol 205: 135\u2013138","journal-title":"Dermatol"},{"key":"1253_CR3","unstructured":"Burke K, David M, Junge K, Sindermann H (1994) Overview on the clinical development of miltefosine solution (Miltex(r)) for the treatment of cutaneous breast cancer. Drugs today 30 [Suppl B]: 59\u201372"},{"key":"1253_CR4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/019459989811800412","volume":"118","author":"Burris","year":"1998","unstructured":"Burris HA, Vogel CL, Castro D et al. (1998) Intratumoral cisplatin\/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study. Otolaryngol Head Neck Surg 118: 496\u2013503","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1253_CR5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00008390-199311000-00011","volume":"3","author":"Cascinelli","year":"1993","unstructured":"Cascinelli N, Clemente C, Bufalino R et al. (1993) Perinodular injection of thymopentin (TP 5) in cutaneous and subcutaneous metastases of melanoma. Mel Res 3: 471\u2013476","journal-title":"Mel Res"},{"key":"1253_CR6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00008390-199412000-00004","volume":"4","author":"Clark","year":"1994","unstructured":"Clark J, Grabs AJ, Parsons PG et al. (1994) Melphalan uptake, hyperthermic synergism and drug resistance in a human cell culture model for the isolated limb perfusion of melanoma. Melanoma Res 4: 365\u2013370","journal-title":"Melanoma Res"},{"key":"1253_CR7","first-page":"938","volume":"60","author":"Creech","year":"1966","unstructured":"Creech O Jr, Krementz E (1966) Techniques of regional perfusion. Surgery 60: 938\u2013947","journal-title":"Surgery"},{"key":"1253_CR8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00000421-199904000-00017","volume":"22","author":"Fenig","year":"1999","unstructured":"Fenig E, Eidelevich E, Njuguna E et al. (1999) Role of radiation therapy in the management of cutaneous malignant melanoma. Am J Clin Oncol 22: 184\u2013186","journal-title":"Am J Clin Oncol"},{"key":"1253_CR9","first-page":"16","volume":"43","author":"Fierlbeck","year":"1992","unstructured":"Fierlbeck G, d\u2019Hoedt B, Stroebel W et al. (1992) Intral\u00e4sionale Therapie von Melanommetastasen mit rekombinantem Interferon-\u03b2. Hautarzt 43: 16\u201321","journal-title":"Hautarzt"},{"key":"1253_CR10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0011-3840(99)80008-2","volume":"36","author":"Fraker","year":"1999","unstructured":"Fraker DL (1999) Hyperthermic regional perfusion for melanoma and sarcoma of the lims. Curr Probl Surg 36: 841\u2013907","journal-title":"Curr Probl Surg"},{"key":"1253_CR11","unstructured":"Garbe C, Hauschild A, Volkenandt M et al. (2005) Deutsche Leitlinie: Malignes Melanom, In: Garbe C (Hrsg) Interdisziplin\u00e4re Leitlinien zur Diagnostik und Behandlung von Hauttumoren. Thieme, Stuttgart, S 23\u201355"},{"key":"1253_CR12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/bjs.4558","volume":"91","author":"Gibson","year":"2004","unstructured":"Gibson SC, Byrne DS, McKay AJ (2004) Ten-year experience of carbon dioxide laser ablation as treatment for cutaneous recurrence of malignant melanoma. Br J Surg 91(7): 893\u2013895","journal-title":"Br J Surg"},{"key":"1253_CR13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejso.2006.01.015","volume":"32","author":"Gr","year":"2006","unstructured":"Gr\u00fcnhagen DJ, de Wilt JH, van Geel AN, Eggermont AM (2006) Isolated limb perfusion for melanoma patients \u2013 a review of its indications and the role of tumor necrosis factor-\u03b1. Eur J Surg Oncol 32: 371\u2013380","journal-title":"Eur J Surg Oncol"},{"key":"1253_CR14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.0022-202x.2001.01427.x","volume":"117","author":"Hoeller","year":"2001","unstructured":"Hoeller C, Jansen B, Heere-Ress E et al. (2001) Perilesional injection of r-GM-CSF in patients with cutaneous melanoma metastases. J Invest Dermatol 117: 371\u2013374","journal-title":"J Invest Dermatol"},{"key":"1253_CR15","first-page":"579","volume":"27","author":"Illig","year":"1976","unstructured":"Illig L, Paul E (1976) Unspezifische epifokale Immuntherapie des malignen Melanoms der Haut mit DNCB nach Malek-Mansour. Hautarzt 27: 579\u2013587","journal-title":"Hautarzt"},{"key":"1253_CR16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0007-1226(73)90040-4","volume":"26","author":"Kaplan","year":"1973","unstructured":"Kaplan I, Ger R, Sharon U (1973) The carbon dioxide laser in plastic surgery. Br J Plast Surg 26: 359\u2013362","journal-title":"Br J Plast Surg"},{"key":"1253_CR17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00128071-200102040-00004","volume":"2","author":"Karrer","year":"2001","unstructured":"Karrer S, Szeimies RM, Hohenleutner U, Landthaler M (2001) Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy. Am J Clin Dermatol 2(4): 229\u2013237","journal-title":"Am J Clin Dermatol"},{"key":"1253_CR18","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1365-2133.2003.05554.x","volume":"149","author":"Katalinic","year":"2003","unstructured":"Katalinic A, Kunze U, Schafer T (2003) Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 149(6): 1200\u20131206","journal-title":"Br J Dermatol"},{"key":"1253_CR19","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/1097-0142(19801115)46:10<2172::AID-CNCR2820461013>3.0.CO;2-L","volume":"46","author":"Kozlov","year":"1980","unstructured":"Kozlov AP, Moskalik KG (1980) Pulsed laser radiation therapy of skin tumors. Cancer 46: 2172\u20132178","journal-title":"Cancer"},{"key":"1253_CR20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1245\/aso.2002.9.2.127","volume":"9","author":"Lindner","year":"2002","unstructured":"Lindner P, Doubrovsky A, Kam PC, Thompson JF (2002) Prognostic factors after isolated limb perfusion with cytotoxic agents for melanoma. Ann Surg Oncol 9: 127\u2013136","journal-title":"Ann Surg Oncol"},{"key":"1253_CR21","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/bjs.1800821016","volume":"82","author":"Lingam","year":"1995","unstructured":"Lingam MK, McKay AJ (1995) Carbon dioxide laser ablation as an alternative treatment for cutaneous metastases from malignant melanoma. Br J Surg 82(10): 1346\u20131348","journal-title":"Br J Surg"},{"key":"1253_CR22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00105-003-0625-z","volume":"55","author":"Loquai","year":"2004","unstructured":"Loquai C, Nashan D, Metze D et al. (2004) Imiquimod, pegyliertes Interferon-\u03b1-2b und Interleukin-2 in der Behandlung kutaner Melanommetastasen. Hautarzt 55:176\u2013181","journal-title":"Hautarzt"},{"key":"1253_CR23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0140-6736(73)92103-X","volume":"2","author":"Malek-Mansour","year":"1973","unstructured":"Malek-Mansour S (1973) Remission of melanoma with DNCB treatment. Lancet 2: 503\u2013504","journal-title":"Lancet"},{"key":"1253_CR24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2133.2002.04867.x","volume":"147","author":"Meier","year":"2002","unstructured":"Meier F, Will S, Ellwanger U et al. (2002) Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol 147(1): 62\u201370","journal-title":"Br J Dermatol"},{"key":"1253_CR25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00008390-200302000-00010","volume":"13","author":"Oratz","year":"2003","unstructured":"Oratz R, Hauschild A, Sebastian G et al. (2003) Intratumoral cisplatin\/adrenaline injectable gel for the treatment of patients with cutaneous and soft tissue metastases of malignant melanoma. Mel Res 13(1): 59\u201366","journal-title":"Mel Res"},{"key":"1253_CR26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(95)90463-8","volume":"345","author":"Overgaard","year":"1995","unstructured":"Overgaard J, Gonzalez Gonzales D, Hulshof MC et al. (1995) Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European society for hyperthermic oncology. Lancet 345: 540\u2013543","journal-title":"Lancet"},{"key":"1253_CR27","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/sj.bjc.6601320","volume":"89","author":"Radny","year":"2003","unstructured":"Radny P, Caroli UM, Bauer J et al. (2003) Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases. Br J Canc 89: 1620\u20131626","journal-title":"Br J Canc"},{"key":"1253_CR28","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/02841860500340340","volume":"44","author":"Ragnarsson-Olding","year":"2005","unstructured":"Ragnarsson-Olding B, Djureen-Martensson E, Mansson-Brahme E, Hansson (2005) Loco-regional control of cutaneous metastases of malignant melanoma by treatment with miltefosine (Miltex). Acta Oncol 44(7): 773\u2013777","journal-title":"Acta Oncol"},{"key":"1253_CR29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2133.2006.07476.x","volume":"155","author":"Rajpar","year":"2006","unstructured":"Rajpar SF, Marsden JR (2006) Imiquimod in the treatment of lentigo maligna. Br J Dermatol 155(4): 653\u2013656","journal-title":"Br J Dermatol"},{"key":"1253_CR30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1610-0387.2006.06054.x","volume":"4","author":"Rapprich","year":"2006","unstructured":"Rapprich H, Hagedorn M (2006) Intral\u00e4sion\u00e4re Behandlung mit Interferon-\u03b2 beim metastasierten Melanom. JDDG 4: 743\u2013746","journal-title":"JDDG"},{"key":"1253_CR31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1468-3083.2001.00254.x","volume":"15","author":"Ridolfi","year":"2001","unstructured":"Ridolfi L, Ridolfi R, Ascari-Raccagni A et al. (2001) Intralesional granulocyte-monocyte colony-stimulating factor followed by subcutaneous interleukin-2 in metastatic melanoma: a pilot study in elderly patients. J Eur Acad Dermatol Venereol 15: 218\u2013223","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1253_CR32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00000658-199809000-00004","volume":"228","author":"Rosenberg","year":"1998","unstructured":"Rosenberg SA, Yang JC, White DE et al. (1998) Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2. Ann Surg 228: 307\u2013319","journal-title":"Ann Surg"},{"key":"1253_CR33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1245\/ASO.2004.03.019","volume":"11","author":"Rossi","year":"2004","unstructured":"Rossi CR, Foletto M, Mocellin S et al. (2004) Hyperthermic isolated limb perfusion with low-dose tumor necrosis factor-\u03b1 and melphalan fur bulky in-transit melanoma metastases. Ann Surg Oncol 11(2): 173\u2013177","journal-title":"Ann Surg Oncol"},{"key":"1253_CR34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0360-3016(91)90051-5","volume":"20","author":"Sauze","year":"1991","unstructured":"Sauze WT (1991) Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Bil Phys 20: 419\u2013432","journal-title":"Int J Radiat Oncol Bil Phys"},{"key":"1253_CR35","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1200\/JCO.1998.16.9.2906","volume":"16","author":"Schraffordt","year":"1998","unstructured":"Schraffordt Koops H, Vaglini M, Suciv S et al.(1998) Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. J Clin Oncol 16: 2906\u20132912","journal-title":"J Clin Oncol"},{"key":"1253_CR36","unstructured":"Sebastian G, Stein A (2006) Das maligne Melanom der Haut. Uni-Med Science, Bremen, S 99"},{"key":"1253_CR37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2230.2002.01151.x","volume":"27","author":"Stanley","year":"2002","unstructured":"Stanley MA (2002) Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol 27: 571\u2013577","journal-title":"Clin Exp Dermatol"},{"key":"1253_CR38","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(06)70758-6","volume":"7","author":"Stevens","year":"2006","unstructured":"Stevens G, McKay MJ (2006) Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma. Lancet Oncol 7(7): 575\u2013583","journal-title":"Lancet Oncol"},{"key":"1253_CR39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00008390-199712000-00010","volume":"7","author":"Strobbe","year":"1997","unstructured":"Strobbe LJ, Hart AA, R\u00fcmke P et al. (1997) Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma. Mel Res 7: 507\u2013512","journal-title":"Mel Res"},{"key":"1253_CR40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0748-7983(97)93726-4","volume":"23","author":"Strobbe","year":"1997","unstructured":"Strobbe LJ, Nieweg OE, Kroon BB (1997) Carbon dioxide laser for cutaneous melanoma metastases: indications and limitations. Eur J Surg Oncol 23(5): 435\u2013438","journal-title":"Eur J Surg Oncol"},{"key":"1253_CR41","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02071525","volume":"16","author":"Thompson","year":"1992","unstructured":"Thompson JF, Gianoutsos MP (1992) Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs. World J Surg 16: 227\u2013233","journal-title":"World J Surg"},{"key":"1253_CR42","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(05)17951-3","volume":"365","author":"Thompson","year":"2005","unstructured":"Thompson JF, Scolyer RA, Kefford RF (2005) Cutaneous Melanoma. Lancet 365: 687\u2013701","journal-title":"Lancet"},{"key":"1253_CR43","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/bjs.1800831004","volume":"83","author":"Vrouenraets","year":"1996","unstructured":"Vrouenraets BC, Nieweg OE, Kroon BB (1996) Thirty-five years of isolated limb perfusion for melanoma: indications and results. Br J Surg 83: 1319\u20131328","journal-title":"Br J Surg"},{"key":"1253_CR44","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","volume":"18","author":"Wieberdink","year":"1982","unstructured":"Wieberdink J, Benck Huysen C, Braat RP et al. (1982) Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol 18: 905\u2013910","journal-title":"Eur J Cancer Clin Oncol"},{"key":"1253_CR45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archderm.139.3.273","volume":"139","author":"Wolf","year":"2003","unstructured":"Wolf IH, Smolle J, Binder B et al. (2003) Topical imiquimod in the treatment of metastatic melanoma to skin. Arch Dermatol 139: 273\u2013276","journal-title":"Arch Dermatol"},{"key":"1253_CR46","doi-asserted-by":"crossref","unstructured":"Wolf P, Rieger E, Kerl H (1993) Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? J Am Acad Dermatol 28(1): 17\u201321. Erratum in: J Am Acad Dermatol 29(1): 41","DOI":"10.1016\/0190-9622(93)70002-B"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-006-1253-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-006-1253-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-006-1253-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T03:37:13Z","timestamp":1558582633000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-006-1253-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["1253"],"URL":"https:\/\/doi.org\/10.1007\/s00105-006-1253-1","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}